Wilson Sonsini Goodrich & Rosati represented Impossible Foods in the case. Impossible Foods secured a victory in a patent infringement litigation that Impossible filed against Motif...
Impossible Foods Inc. v. Motif Foodworks, Inc.
OneSkin’s $7 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised OneSkin on intellectual property matters related to the transaction. OneSkin, a biotech skin health brand, announced the completion of an...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
Cellino’s $80 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Cellino on the deal. Cellino Biotech, an autonomous cell therapy manufacturing company, announced the completion of a Series A financing...
Vigil Neuroscience’s $90 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Vida Ventures on the deal while Goodwin Procter represented Vigil Neuroscience. Vigil Neuroscience, a biotechnology company harnessing the power of...